SCHEMBL5351709

SCHEMBL5351709

Cc1cc(C=O)cc(C)c1OCCOc1c(C)cc(C=O)cc1C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRC P12931 1/20 0.53
FDPS P14324 1/20 0.43
ALDH1A1 P00352 5/20 0.43
KMT2A Q03164 4/20 0.43
MEN1 O00255 3/20 0.43
MAPT P10636 3/20 0.43
HPGD P15428 2/20 0.43
POLB P06746 1/20 0.43
ALOX12 P18054 1/20 0.43
MAPK1 P28482 1/20 0.43
RECQL P46063 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
KDM4E B2RXH2 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
LMNA P02545 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
HTT P42858 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL347037 0.92 SRC (0.51) SRCFDPSALDH1A1KMT2AMEN1
SCHEMBL8612271 0.92 SRC (0.50) SRCFDPSALDH1A1KMT2AMEN1
SCHEMBL5144244 0.88 SRC (0.47) SRCALDH1A1KMT2AMEN1MAPT
SCHEMBL147201 0.88 SRC (0.51) SRCFDPSALDH1A1KMT2AMEN1
SCHEMBL2651217 0.88 SRC (0.47) SRCFDPSALDH1A1KMT2AMEN1
SCHEMBL378363 0.87 SRC (0.50) SRCFDPSALDH1A1KMT2AMEN1
SCHEMBL7679676 0.87 SRC (0.46) SRCFDPSALDH1A1KMT2AMEN1
SCHEMBL10014676 0.86 SRC (0.42) SRCFDPSALDH1A1KMT2AMEN1
SCHEMBL8035224 0.85 THRA (0.51) SRCALDH1A1KMT2AMEN1MAPT
SCHEMBL16795268 0.85 KDM4E (0.49) SRCALDH1A1KMT2AMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7169446-B2 Oxetane compound, actinic ray curable composition, ink composition for ink jet recording, and image formation method KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2007-01-30 US disclosed
EP-1486526-B1 Oxetane compound, actinic ray curable composition, ink composition for ink jet recording, and image formation method KONICA MINOLTA MED & GRAPHIC (JP) 2006-08-16 EP disclosed
US-20040252171-A1 Oxetane compound, actinic ray curable composition, ink composition for ink jet recording, and image formation method KONICA MINOLTA MEDICAL & GRAPHIC, INC. 2004-12-16 US disclosed
EP-1486526-A1 Oxetane compound, actinic ray curable composition, ink composition for ink jet recording, and image formation method Konica Minolta Medical & Graphic, Inc. (JP) 2004-12-15 EP disclosed